Renal Disease: Chronic Kidney Disease

sec_arr References
SECTIONS

References

  1. Kidney Disease Improving Global Outcomes (KDIGO). 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Supplements. 2024 105:S117-S314. Available at: https://www.kidney-international.org/article/S0085-2538(0023)00766-00764/fulltext.
  2. American Kidney Fund. Quick Kidney Disease Facts and Stats. July 2024. Available at: https://www.kidneyfund.org/all-about-kidneys/quick-kidney-disease-facts-and-stats#:~:text=Kidney%20disease%20is%20growing%20at,with%20kidney%20failure%20in%202021.
  3. Thomas R, Kanso A, Sedor JR. Chronic kidney disease and its complications. Prim Care. 2008;35:329-344, vii.
  4. Mukhopadhyay P, Sinha U, Banerjee J, Choudhury AR, Philips CA. The effects in correction of anaemia in chronic kidney disease with erythropoietin therapy–preference to cardiovascular, neurologic and general well-being of patients from a tertiary care centre. J Indian Med Assoc. 2012;110:885-888.
  5. Rocco MV, Gassman JJ, Wang SR, Kaplan RM. Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. Am J Kidney Dis. 1997;29:888-896.
  6. Kittiskulnam P, Sheshadri A, Johansen KL. Consequences of CKD on functioning. Semin Nephrol. 2016;36:305-318.
  7. Ito O. Renal rehabilitation in patients with chronic kidney disease. Phys Med Rehabil Res. 2017;2:1-4.
  8. Leikis MJ, McKenna MJ, Petersen AC, et al. Exercise performance falls over time in patients with chronic kidney disease despite maintenance of hemoglobin concentration. Clin J Am Soc Nephrol. 2006;1:488-495.
  9. Padilla J, Krasnoff J, Da Silva M, et al. Physical functioning in patients with chronic kidney disease. J Nephrol. 2008;21:550-559.
  10. Johansen KL, Painter P. Exercise in individuals with CKD. Am J Kidney Dis. 2012;59:126-134.
  11. Bronas UG, Puzantian H, Hannan M. Cognitive impairment in chronic kidney disease: Vascular milieu and the potential therapeutic role of exercise. Biomed Res Int. 2017;2017:2726369.
  12. Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G, Massy ZA. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J Am Soc Nephrol. 2013;24:353-363.
  13. Kepecs DM, Glick L, Silver SA, Yuen DA. Does chronic kidney disease-induced cognitive impairment affect driving safety? Can J Kidney Health Dis. 2018;5:2054358118777133.
  14. Dad T, Weiner DE. Stroke and chronic kidney disease: Epidemiology, pathogenesis, and management across kidney disease stages. Semin Nephrol. 2015;35:311-322.
  15. Nayak-Rao S, Shenoy MP. Stroke in patients with chronic kidney disease…How do we approach and manage it? Indian J Nephrol. 2017;27:167-171.
  16. Caravaca F, Chavez E, Alvarado R, Garcia-Pino G, Luna E. Sudden cardiac death in non-dialysis chronic kidney disease patients. Nefrologia. 2016;36:404-409.
  17. Deo R, Fyr CL, Fried LF, et al. Kidney dysfunction and fatal cardiovascular disease–an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study. Am Heart J. 2008;155:62-68.
  18. Deo R, Lin F, Vittinghoff E, Tseng ZH, Hulley SB, Shlipak MG. Kidney dysfunction and sudden cardiac death among women with coronary heart disease. Hypertension. 2008;51:1578-1582.
  19. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382:339-352.
  20. Sarnak M, Gibson M, Henrich W. Chronic Kidney Disease and Coronary Artery Disease. Up To Date. December 6, 2017.
  21. Whitman IR, Feldman HI, Deo R. CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches. J Am Soc Nephrol. 2012;23:1929-1939.
  22. Lutz J, Menke J, Sollinger D, Schinzel H, Thurmel K. Haemostasis in chronic kidney disease. Nephrol Dial Transplant. 2014;29:29-40.
  23. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116:85-97.
  24. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol. 2016;23:NP1-NP96.
  25. Kato S, Chmielewski M, Honda H, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3:1526-1533.
  26. Kalantar-Zadeh K, Fouque D. Nutritional management of chronic kidney disease. N Engl J Med. 2017;377:1765-1776.
  27. Michigan Quality Improvement Consortium. Guideline Diagnosis and Management of Adults with Chronic Kidney Disease. November 2020. Available at: https://www.med.umich.edu/1libr/CCG/CKD.mqic.pdf.
  28. National Kidney Foundation. eGFR Calculator. Available at: https://www.kidney.org/professionals/kdoqi/gfr_calculator.
  29. Inker L, Perrone R. Assessment of kidney function. Up To Date. June 12, 2018.
  30. Teruel Briones JL, Gomis Couto A, Sabater J, et al. Validation of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation in advanced chronic renal failure. Nefrologia. 2011;31:677-682.
  31. U.S. Preventive Services Task Force. Chronic Kidney Disease: Screening. 2012. Available at: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/chronic-kidney-disease-ckd-screening.
  32. Roberts J. Urinalysis Microscopy. Emergency Medicine News July 2007;29:20-22.
  33. Wein A, Kavoussi L, Novick A, et al. Campbell-Walsh Urology, 10th Edition: Saunders; 2011.
  34. Kurella M, Chertow GM, Fried LF, et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol. 2005;16:2127-2133.
  35. Sajjad I, Grodstein F, Kang JH, Curhan GC, Lin J. Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol. 2012;7:437-443.
  36. Murray AM, Barzilay JI, Lovato JF, et al. Biomarkers of renal function and cognitive impairment in patients with diabetes. Diabetes Care. 2011;34:1827-1832.
  37. Gregory SM, Headley SA, Germain M, et al. Lack of circulating bioactive and immunoreactive IGF-I changes despite improved fitness in chronic kidney disease patients following 48 weeks of physical training. Growth Horm IGF Res. 2011;21:51-56.
  38. Mustata S, Groeneveld S, Davidson W, Ford G, Kiland K, Manns B. Effects of exercise training on physical impairment, arterial stiffness and health-related quality of life in patients with chronic kidney disease: a pilot study. Int Urol Nephrol. 2011;43:1133-1141.
  39. Brodin E, Ljungman S, Sunnerhagen KS. Rising from a chair: a simple screening test for physical function in predialysis patients. Scand J Urol Nephrol. 2008;42:293-300.
  40. Bowling CB, Sawyer P, Campbell RC, Ahmed A, Allman RM. Impact of chronic kidney disease on activities of daily living in community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2011;66:689-694.
  41. Odden MC, Whooley MA, Shlipak MG. Association of chronic kidney disease and anemia with physical capacity: the heart and soul study. J Am Soc Nephrol. 2004;15:2908-2915.
  42. Fried LF, Lee JS, Shlipak M, et al. Chronic kidney disease and functional limitation in older people: health, aging and body composition study. J Am Geriatr Soc. 2006;54:750-756.
  43. McManus D, Shlipak M, Ix JH, Ali S, Whooley MA. Association of cystatin C with poor exercise capacity and heart rate recovery: data from the heart and soul study. Am J Kidney Dis. 2007;49:365-372.
  44. Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006;54:991-1001.
  45. Shlipak MG, Stehman-Breen C, Fried LF, et al. The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis. 2004;43:861-867.
  46. Roshanravan B, Khatri M, Robinson-Cohen C, et al. A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis. 2012;60:912-921.
  47. Sachdev PS, Blacker D, Blazer DG, et al. Classifying neurocognitive disorders: the DSM-5 approach. Nat Rev Neurol. 2014;10:634-642.
  48. American Psychiatric Association, DSM-5 Task Force. Diagnostic and Statistical Manual of Mental Disorders: DSM-5™ (5th ed.) American Psychiatric Publishing, Inc. ; 2013. https://doi.org/10.1176/appi.books.9780890425596.
  49. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1133-1142.
  50. Gesualdo GD, Duarte JG, Zazzetta MS, et al. Cognitive impairment of patients with chronic renal disease on hemodialysis and its relationship with sociodemographic and clinical characteristics. Dement Neuropsychol. 2017;11:221-226.
  51. Hailpern SM, Melamed ML, Cohen HW, Hostetter TH. Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol. 2007;18:2205-2213.
  52. Yaffe K, Ackerson L, Kurella Tamura M, et al. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc. 2010;58:338-345.
  53. Etgen T. Kidney disease as a determinant of cognitive decline and dementia. Alzheimers Res Ther. 2015;7:29.
  54. Davey A, Elias MF, Robbins MA, Seliger SL, Dore GA. Decline in renal functioning is associated with longitudinal decline in global cognitive functioning, abstract reasoning and verbal memory. Nephrol Dial Transplant. 2013;28:1810-1819.
  55. Elias MF, Elias PK, Seliger SL, Narsipur SS, Dore GA, Robbins MA. Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant. 2009;24:2446-2452.
  56. Kurella M, Chertow GM, Luan J, Yaffe K. Cognitive impairment in chronic kidney disease. J Am Geriatr Soc. 2004;52:1863-1869.
  57. Kurella M, Yaffe K, Shlipak MG, Wenger NK, Chertow GM. Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis. 2005;45:66-76.
  58. Kurella Tamura M, Wadley V, Yaffe K, et al. Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis. 2008;52:227-234.
  59. Madan P, Kalra OP, Agarwal S, Tandon OP. Cognitive impairment in chronic kidney disease. Nephrol Dial Transplant. 2007;22:440-444.
  60. Brodski J, Rossell SL, Castle DJ, Tan EJ. A systematic review of cognitive impairments associated with kidney failure in adults before natural age-related changes. J Int Neuropsychol Soc. 2019;25:101-114.
  61. Koushik NS, McArthur SF, Baird AD. Adult chronic kidney disease: neurocognition in chronic renal failure. Neuropsychol Rev. 2010;20:33-51.
  62. Etgen T, Sander D, Chonchol M, et al. Chronic kidney disease is associated with incident cognitive impairment in the elderly: the INVADE study. Nephrol Dial Transplant. 2009;24:3144-3150.
  63. Seliger SL, Siscovick DS, Stehman-Breen CO, et al. Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J Am Soc Nephrol. 2004;15:1904-1911.
  64. Buchman AS, Tanne D, Boyle PA, Shah RC, Leurgans SE, Bennett DA. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology. 2009;73:920-927.
  65. Khatri M, Nickolas T, Moon YP, et al. CKD associates with cognitive decline. J Am Soc Nephrol. 2009;20:2427-2432.
  66. Barzilay JI, Lovato JF, Murray AM, et al. Albuminuria and cognitive decline in people with diabetes and normal renal function. Clin J Am Soc Nephrol. 2013;8:1907-1914.
  67. Georgakis MK, Dimitriou NG, Karalexi MA, et al. Albuminuria in association with cognitive function and dementia: A systematic review and meta-analysis. J Am Geriatr Soc. 2017;65:1190-1198.
  68. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
  69. McDowell I, Kristjansson B, Hill GB, Hebert R. Community screening for dementia: the Mini Mental State Exam (MMSE) and Modified Mini-Mental State Exam (3MS) compared. J Clin Epidemiol. 1997;50:377-383.
  70. Corrigan JD, Hinkeldey NS. Relationships between parts A and B of the Trail Making Test. J Clin Psychol. 1987;43:402-409.
  71. Post JB, Jegede AB, Morin K, Spungen AM, Langhoff E, Sano M. Cognitive profile of chronic kidney disease and hemodialysis patients without dementia. Nephron Clin Pract. 2010;116:c247-255.
  72. Slinin Y, Paudel ML, Ishani A, et al. Kidney function and cognitive performance and decline in older men. J Am Geriatr Soc. 2008;56:2082-2088.
  73. Helmer C, Stengel B, Metzger M, et al. Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. Neurology. 2011;77:2043-2051.
  74. Kamouchi M. Stroke features and management in patients with chronic kidney disease. Contrib Nephrol. 2013;179:92-99.
  75. Bao YS, Song LT, Zhong D, et al. Epidemiology and risk factors for chronic kidney disease in patients with ischaemic stroke. Eur J Clin Invest. 2013;43:829-835.
  76. Holzmann MJ, Aastveit A, Hammar N, Jungner I, Walldius G, Holme I. Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population. Ann Med. 2012;44:607-615.
  77. Jeon JW, Jeong HS, Choi DE, et al. Prognostic relationships between microbleed, lacunar infarction, white matter lesion, and renal dysfunction in acute ischemic stroke survivors. J Stroke Cerebrovasc Dis. 2017;26:385-392.
  78. Laible M, Horstmann S, Mohlenbruch M, et al. Renal dysfunction is associated with deep cerebral microbleeds but not white matter hyperintensities in patients with acute intracerebral hemorrhage. J Neurol. 2015;262:2312-2322.
  79. Shima H, Ishimura E, Naganuma T, et al. Cerebral microbleeds in predialysis patients with chronic kidney disease. Nephrol Dial Transplant. 2010;25:1554-1559.
  80. Shima H, Mori T, Ooi M, et al. Silent cerebral microbleeds and longitudinal risk of renal and cardiovascular events in patients with CKD. Clin J Am Soc Nephrol. 2016;11:1557-1565.
  81. El Husseini N, Fonarow GC, Smith EE, et al. Renal dysfunction is associated with poststroke discharge disposition and in-hospital mortality: Findings from Get with the Guidelines-Stroke. Stroke. 2017;48:327-334.
  82. Yamamoto S, Kon V. Mechanisms for increased cardiovascular disease in chronic kidney dysfunction. Curr Opin Nephrol Hypertens. 2009;18:181-188.
  83. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
  84. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659-663.
  85. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int. 1999;56:2214-2219.
  86. Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ. Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2006;151:492-500.
  87. Klausen KP, Scharling H, Jensen JS. Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases. J Intern Med. 2006;260:231-237.
  88. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073-2081.
  89. Mok Y, Ballew SH, Matsushita K. Prognostic value of chronic kidney disease measures in patients with cardiac disease. Circ J. 2017;81:1075-1084.
  90. Chinnappa S, White E, Lewis N, et al. Early and asymptomatic cardiac dysfunction in chronic kidney disease. Nephrol Dial Transplant. 2018;33:450-458.
  91. Kottgen A, Russell SD, Loehr LR, et al. Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol. 2007;18:1307-1315.
  92. Wattanakit K, Folsom AR, Selvin E, Coresh J, Hirsch AT, Weatherley BD. Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol. 2007;18:629-636.
  93. Alonso A, Lopez FL, Matsushita K, et al. Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011;123:2946-2953.
  94. Sarnak MJ, Levey AS. Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease. J Thromb Thrombolysis. 2000;10:169-180.
  95. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis. 1996;27:347-354.
  96. Tucker B, Fabbian F, Giles M, Thuraisingham RC, Raine AE, Baker LR. Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant. 1997;12:724-728.
  97. Matsushita K, Coresh J, Sang Y. Kidney measures beyond traditional risk factors for cardiovascular prediction: A collaborative meta-analysis. Lancet Diabetes Endocrinol. 2015;3:514-525.
  98. Virani S, Alonso A, Benjamin E, et al. Heart disease and stroke statistics—2020 update: A report from the American Heart Association. Circulation. 2020. Available at: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000757;141.
  99. Di Lullo L, Rivera R, Barbera V, et al. Sudden cardiac death and chronic kidney disease: From pathophysiology to treatment strategies. Int J Cardiol. 2016;217:16-27.
  100. Turakhia MP, Blankestijn PJ, Carrero JJ, et al. Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Eur Heart J. 2018;39:2314-2325.
  101. Olesen JB, Lip GY, Kamper AL, et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med. 2012;367:625-635.
  102.  Piccini JP, Stevens SR, Chang Y, et al. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct f  factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation. 2013;127:224-232.
  103.  Providencia R, Marijon E, Boveda S, et al. Meta-analysis of the influence of chronic kidney disease on the risk of thromboembolism among patients with nonvalvular atrial fibrillation. Am J Cardiol. 2014;114:646-653.
  104.  Palmer K, Brown I, Hobson J, (Eds.). Fitness for Work: The Medical Aspects, 5th Edition: Oxford University Press; 2013.
  105.  Hardinger K, Brennan D. Kidney Transplantation in Adults: Maintenance Immuosuprressive Therapy. Up To Date. August 7, 2020.
  106.  Chisholm-Burns MA, Erickson SR, Spivey CA, Kaplan B. Health-related quality of life and employment among renal transplant recipients. Clin Transplant. 2012;26:411-417.
  107.  Manninen DL, Evans RW, Dugan MK. Work disability, functional limitations, and the health status of kidney transplantation recipients posttransplant. Clin Transpl. 1991:193-203.
  108.  van der Mei SF, Kuiper D, Groothoff JW, van den Heuvel WJ, van Son WJ, Brouwer S. Long-term health and work outcomes of renal transplantation and patterns of work status during the end-stage renal disease trajectory. J Occup Rehabil.  2011;21:325-334.
  109.  Nour N, Heck CS, Ross H. Factors related to participation in paid work after organ transplantation: perceptions of kidney transplant recipients. J Occup Rehabil. 2015;25:38-51.
  110.  Atallah AM, Farag SM, Senna MK, Ghoneim MA. Musculoskeletal affections among kidney recipients: prevalence and risk predictors. Rheumatol Int. 2008;28:1085-1090.